An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India

BACKGROUND: Better drug regimens for mass drug administration (MDA) could accelerate the Global Programme to Eliminate Lymphatic Filariasis (LF). This community study was designed to compare the safety and efficacy of MDA with IDA (ivermectin, diethylcarbamazine and albendazole) or DA (diethylcarbam...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS Negl Trop Dis
Main Authors: Jambulingam, Purushothaman, Kuttiatt, Vijesh Sreedhar, Krishnamoorthy, Kaliannagounder, Subramanian, Swaminathan, Srividya, Adinarayanan, Raju, Hari Kishan K., Rahi, Manju, Somani, Roopali K., Suryaprakash, Mallanna K., Dwivedi, Gangeshwar P., Weil, Gary J.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7909694/
https://ncbi.nlm.nih.gov/pubmed/33591979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0009069
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados